Citizens, Inc. (CIA)
NYSE: CIA · Real-Time Price · USD
3.990
+0.210 (5.56%)
At close: May 12, 2025, 4:00 PM
3.990
0.00 (0.00%)
After-hours: May 12, 2025, 7:00 PM EDT

Company Description

Citizens, Inc., an insurance holding company, provides life insurance products in the United States and internationally.

The company operates in two segments, Life Insurance and Home Service Insurance. The Life Insurance segment sells U.S. dollar-denominated whole life insurance, endowment, and critical illness policies to non-U.S. residents through independent marketing agencies and consultants.

The Home Service Insurance segment offers final expense life insurance and critical illness products to middle- and lower-income households in Louisiana, Mississippi and Arkansas.

This segment provides its products and services through funeral homes and independent agents. It also provides accident and health insurance policies.

Citizens, Inc. was founded in 1969 and is headquartered in Austin, Texas.

Citizens, Inc.
Citizens logo
Country United States
Founded 1969
Industry Insurance - Life
Sector Financials
Employees 250
CEO Jon Stenberg

Contact Details

Address:
11815 Alterra Parkway, Suite 1500
Austin, Texas 78758
United States
Phone 512 837 7100
Website citizensinc.com

Stock Details

Ticker Symbol CIA
Exchange NYSE
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000024090
CUSIP Number 174740100
ISIN Number US1747401008
Employer ID 84-0755371
SIC Code 6311

Key Executives

Name Position
Jon Scott Stenberg President and Chief Executive Officer
Jeffery Paul Conklin Chief Financial Officer, Chief Investment Officer and Treasurer
Sheryl L. Kinlaw J.D. Chief Legal Officer and Secretary
Bryon Matthew Lewis Chief Operating Officer
Paula Guerrero Chief Information Officer
David Scott Jorgensen CPA General Manager for International Operations of CICA Life Insurance Company of America
Harvey J. L. Waite Chief Actuary

Latest SEC Filings

Date Type Title
May 8, 2025 10-Q Quarterly Report
May 8, 2025 8-K Current Report
Apr 30, 2025 ARS Filing
Apr 30, 2025 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 30, 2025 DEF 14A Other definitive proxy statements
Apr 11, 2025 8-K Current Report
Mar 13, 2025 10-K Annual Report
Mar 13, 2025 8-K Current Report
Dec 9, 2024 424B3 Prospectus
Dec 6, 2024 EFFECT Notice of Effectiveness